21st Century Approach to Healthy Lifestyle. The Stem Cell Therapy.
The human body is made of a system of functional cells structured in organs. The lifetime of these cells is limited. In other words, the human body dies close to 15-20 pounds daily and is simultaneously regenerated by the same value. We need to bring nutrients of all types to keep the functionality going. Aging means limited life expectancy and functionality to tissues in human structure, and malnutrition in our daily diet can cause acute and chronic functional conditions that need special attention.
In the search for regeneration of the human body, fallen ill or aged, regenerative medicine concluded that it is the source of potential recovery and repair. However, the complexity of the human biological mechanism revealed that cell therapy works more effectively when combined with other therapeutic combinations. We evaluate your condition first and recommend the ideal single or combined treatment approach.
A source of pluripotent (potential to adapt and functionality in damaged and aged tissue) innocent unprogrammed cells called stem cells in the past 20 years has been identified in Umbilical Cord Blood as the source of stem cells that can also differentiate across tissue lineage boundaries into neural, cardiac, epithelial, hepatocytic, mucosal, and dermal tissue.
Stem Cell Therapy is a novel line of therapy in several conditions.
I- Endocrine Diseases:
- Diabetes Type 2,
- Hashimoto Thyroiditis,
- Hypothyroidism
II- Digestive System:
- Crohn’s Disease, Chronic Ulcerative Colitis
- Peptic Ulceration
- Chronic Pancreatitis
- Liver Cirrhosis
III- Respiratory Disease:
- COPD Disease, Emphysema
- Pulmonary Fibrosis, Asthma
IV- Musculoskeletal
- Fibromyalgia, Gout, Chronic Fatigue Syndrome
- Dermatomyositis
- Spinal Cord Injuries
- Athletic Performance Improvement, Resistant Athletic Injuries
V- Neurological
- Multiple Sclerosis Symptoms, Parkinsonism
- ALS-Amyotrophic Lateral Sclerosis, Motor Neuron Disease
- Ataxia
- Autism
- Post Stroke Symptoms
VI- Cardiovascular Disease
- Post Stroke Recovery
- Hypertension
- Cerebral Small Vessel Disease
VII- Rheumatic Disease
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
Umbilical cord (UCB) and placenta-derived stem cells represent a promising future source for tissue repair and regeneration. The widespread availability of UCB makes it an attractive option for such purposes. UCB-derived stem cells offer several advantages over adult stem cells, including their immaturity, which may reduce rejection rates when transplanted into mismatched hosts, and their capacity to produce larger quantities of homogeneous tissue or cells.
While research involving embryonic stem cells remains controversial, human umbilical stem cells offer an ethically acceptable alternative that enjoys broad public support. Numerous studies and reviews have explored the potential therapeutic applications of UCB stem cells for non-hematopoietic tissue and cell regeneration.
Stem cells are harvested from umbilical cord blood under controlled conditions. They undergo a specialized processing procedure and receive approval from relevant authorities before being made available for use.
Individual candidates first must be interviewed, their medical condition for treatment evaluated, and available regenerative solutions for them. Following pre-procedural evaluation and education, consent will be obtained. The patient will be scheduled for the intravenous administration of stem cells, diluted in a sterile bag of normal saline or equivalent solution, administered in 30-45 minutes. Other appropriate options are introduced on the real needs of individual patients.